Product
Supplier
Encyclopedia
Inquiry
Home > News > Market Flash
ECHEMI chemical news

Market Flash

Gattefossé Unveiled its first Hair Care Ingredient at in-cosmetics Latin America

Gattefossé Unveiled its first Hair Care Ingredient at in-cosmetics Latin America

2018-10-16

Gattefossé launched its first ever hair care ingredient at in-cosmetics Latin America - Definicire™. The researchers have applied their knowledge in lipochemistry to develop an ingredient that mimics the beneficial conditioning and protective properties

Afton Chemical completes second phase expansion in Singapore

Afton Chemical completes second phase expansion in Singapore

2018-10-16

Afton Chemical completes second phase expansion in Singapore.

Daily Chemical News Recommendation ( Oct. 16  2018)

Daily Chemical News Recommendation ( Oct. 16 2018)

2018-10-16

The bankruptcy court has asked creditors of Nagarjuna Oil Corporation to explain the basis of liquidation value of the Chennai-based company’s assets and why it rejected some resolution plans. The Committee of Creditors (CoC) has to submit its explanation

China's MEG price rises amid expectation of futures contract on the DCE

China's MEG price rises amid expectation of futures contract on the DCE

2018-10-15

China's Dalian Commodity Exchange plans to accelerate the launch of a monoethylene glycol futures contract, together with some other commodities, the DCE's CEO Wang Fenghai said at the Institutional Commodity Derivatives Forum 2018 in Dalian last Thursday

Gulf Oil looks to raise share in domestic lubricants market

Gulf Oil looks to raise share in domestic lubricants market

2018-10-12

Helped by a higher-than-industry growth thanks to its multi-pronged strategy, Gulf Oil Lubricants is eyeing the number 2 position among private players in the domestic lubricants market.

Glenmark enters into licensing agreement to commercialise dry powder inhaler

Glenmark enters into licensing agreement to commercialise dry powder inhaler

2018-10-12

Glenmark Pharmaceuticals Ltd. has announced that Glenmark Pharmaceuticals Europe has entered into a strategic, exclusive licensing agreement for marketing generic tiotropium bromide dry powder inhaler (DPI) in Western Europe. Tiotropium bromide DPI is a g

NeuroVive Receives KL1333 Clinical Trial Regulatory Approval

NeuroVive Receives KL1333 Clinical Trial Regulatory Approval

2018-10-12

NeuroVive Pharmaceutical has received approval of its clinical trial application concerning a planned phase I KL1333 study in patients and healthy volunteers from the UK regulatory authority, Medicines and Healthcare products Regulatory Agency (MHRA).

IAVI Announces Clinical Trial of HIV Vaccine Candidate

IAVI Announces Clinical Trial of HIV Vaccine Candidate

2018-10-12

The International AIDS Vaccine Initiative (IAVI) announces the start of a Phase I clinical trial (IAVI G001) to test a novel vaccine candidate designed to stimulate the immune system to initiate a first step in the generation of potent proteins, known as

Nanoreactors to synthesise organic substances

Nanoreactors to synthesise organic substances

2018-10-12

A RUDN University chemist developed a new type of photocatalysts – nanostructures from titanium dioxide. Hollow nanocubes with ultra-thin walls act like nanoreactors and provide for 28 fold more effective organic reactions at room temperature under the in

New Data Released on Stelara for Ulcerative Colitis

New Data Released on Stelara for Ulcerative Colitis

2018-10-12

In addition, both doses of Stelara resulted in statistically significant improvements in the Inflammatory Bowel Disease Questionnaire (IBDQ), a health-related quality of life measure for patients with IBD, as well as markers of inflammation, including C-r

Ionis Enters Collaboration with Partner to Develop IONIS-FB-LRx

Ionis Enters Collaboration with Partner to Develop IONIS-FB-LRx

2018-10-12

Ionis announced a new collaboration with Roche to develop IONIS-FB-LRx for the treatment of complement-mediated diseases. This collaboration will leverage Ionis' leadership in RNA-targeted therapeutics to develop IONIS-FB-LRx targeting Factor B (FB) for a

Pharmaxis Releases Positive Results of for LOXL2 Trial

Pharmaxis Releases Positive Results of for LOXL2 Trial

2018-10-12

Pharmaxis announced positive results from the Phase 1 clinical trial for the first of its Lysyl Oxidase Like 2 (LOXL2) inhibitor compounds being developed to treat fibrotic diseases such as Non‐Alcoholic Steatohepatitis (NASH) and Idiopathic Pulmonary Fib

Bristol-Myers Squibb, Compugen Announce Clinical Collaboration

Bristol-Myers Squibb, Compugen Announce Clinical Collaboration

2018-10-12

Under the terms of the share purchase agreement, Bristol-Myers Squibb will make a $12 million investment in Compugen comprised of 2,424,243 shares of Compugen stock purchased at $4.95 per share, representing a 33% premium over the average closing price on

Carrick bags ex-Onyx cancer drug, plans pivotal trials

Carrick bags ex-Onyx cancer drug, plans pivotal trials

2018-10-12

Onyx paid BTG $13 million up front to license the drug in 2008 and handed over a further $7 million when it secured clearance to run a p...

Crude oil to chemicals - an emerging challenge for the chemical industry - Ravi

Crude oil to chemicals - an emerging challenge for the chemical industry - Ravi

2018-10-11

The first dynamic is the on-going transformation in the automotive industry. Electric vehicles (EVs) in different avatars such as hybrids and all-electric are now a reality in some countries, albeit not in large numbers.

Australian Competition and Consumer Commission clears Arrow and Apotex merger: S

Australian Competition and Consumer Commission clears Arrow and Apotex merger: S

2018-10-10

Strides Pharma Science has said that the Australian Competition and Consumer Commission (ACCC) has deci-ded not to oppose the merger of generic pharma companies Arrow and Apotex, after finding the transaction would not substantially lessen competition in

Aurobindo gets South African nod for HIV drug

Aurobindo gets South African nod for HIV drug

2018-10-10

Prior to SAHPRA’s approval, Aurobindo has received tentative approval for the drug from US Food and Drug Administration and launched in Sub-Saharan African markets.

US grains body asks India to allow ethanol imports to lower crude oil import bil

US grains body asks India to allow ethanol imports to lower crude oil import bil

2018-10-10

Allowing imports of ethanol can help lower the country’s crude oil import bill, according to the US Grains Council (USGC), a global biofuel promoting organisation.

Supreme Court issues notice to government on petition seeking ban on 85 pesticid

Supreme Court issues notice to government on petition seeking ban on 85 pesticid

2018-10-10

A bench of Justices Arun Misra and Vineet Saran issued notices to the Centre and other authorities concerned on the plea which also sought empowering state governments to take decisions at their level for prohibition and restriction related to pesticides.

Perfumery and aromatherapy workshop held in Dehradun

Perfumery and aromatherapy workshop held in Dehradun

2018-10-10

The Chemistry and Bioprospecting Division of Forest Research Institute (FRI) along with the Fragrance and Flavour Development Centre, Kannauj, jointly organised a five-day training-cum-workshop on essential oils, perfumery and aroma-therapy from September

  • Life Sciences Industry Overview

    The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.
    Published in: June.2026
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.